Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dauh-Rurng Wu

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
ACS Medicinal Chemistry Letters|December 18, 2020
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening ApproachQingjie Liu, Douglas G Batt, Carolyn A Weigelt, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variationsZili Xiao, Michael G Yang, Chunjian Liu, et al.
Journal of Medicinal Chemistry|February 16, 2021
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313Michael G Yang, Myra Beaudoin-Bertrand, Zili Xiao, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 InhibitorsChunjian Liu, James Lin, Ryan Moslin, et al.
The Journal of Organic Chemistry|July 8, 2015
Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte DevelopmentScott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2020
Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists - Exploring C6 and C8 SAR using late-stage functionalizationQing Shi, Zili Xiao, Michael G Yang, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2015
BMS-871: a novel orally active pan-Notch inhibitor as an anticancer agentWeifang Shan, Aaron Balog, Claude Quesnelle, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of CancerChristine M Tarby, Amy Hart, Honghe Wan, et al.
Medchemcomm|August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulatorsDavid Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|December 18, 2020
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening ApproachQingjie Liu, Douglas G Batt, Carolyn A Weigelt, et al.
The Journal of Organic Chemistry|September 7, 2017
Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097Arvind Mathur, Bei Wang, Daniel Smith, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variationsZili Xiao, Michael G Yang, Chunjian Liu, et al.
Journal of Medicinal Chemistry|February 16, 2021
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313Michael G Yang, Myra Beaudoin-Bertrand, Zili Xiao, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 InhibitorsChunjian Liu, James Lin, Ryan Moslin, et al.
The Journal of Organic Chemistry|July 8, 2015
Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte DevelopmentScott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2020
Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists - Exploring C6 and C8 SAR using late-stage functionalizationQing Shi, Zili Xiao, Michael G Yang, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2015
BMS-871: a novel orally active pan-Notch inhibitor as an anticancer agentWeifang Shan, Aaron Balog, Claude Quesnelle, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of CancerChristine M Tarby, Amy Hart, Honghe Wan, et al.
Medchemcomm|August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulatorsDavid Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Pageof 7